Recruiting studies: Ectodermal Dysplasia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

FARD (RaDiCo Cohort) (RaDiCo-FARD)
Phase N/A · 15 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05954416 Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Phase N/A · 1 location(s) · Maastricht University Medical Center · NCT06330350 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168 Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia
Phase 2 · 8 location(s) · EspeRare Foundation · NCT04980638 Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)
Phase N/A · 1 location(s) · UConn Health · NCT01630421 A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults Wit
Phase 3 · 1 location(s) · Palvella Therapeutics, Inc. · NCT05643872 International Pachyonychia Congenita Research Registry
Phase N/A · 1 location(s) · Pachyonychia Congenita Project · NCT02321423 Organization's Unique Protocol ID
NA · 1 location(s) · Cairo University · NCT07468019 Institutional Registry of Rare Diseases
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06573723 CDH1-associated Blepharocheilodontic Syndrome Registry
Phase N/A · 1 location(s) · Ohio State University · NCT07133464

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.